These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5061165)

  • 21. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of menstrual disorders with a combination of norgestrel and ethynyl estradiol.
    Rao KP
    Curr Med Pract; 1971; 15(1):586-9. PubMed ID: 12306340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A; Rouffy J; Upmalis D; Dain MP
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract]   [Full Text] [Related]  

  • 24. Oestroprogestogen interference on some haematochemical parameters: glycaemia, lipid metabolism and hepatic functionality (author's transl).
    Chieffi O; Brogioni M; Saltarelli O; Pecchioli S; Benardi M
    Patol Clin Ostet Ginecol; 1981; 9(1):7-17. PubMed ID: 12278646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 26. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
    Moggia AV
    J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norgestrel, increased lipids: fact or "marketing monster"?
    Contracept Technol Update; 1989 Oct; 10(10):133-8. PubMed ID: 12342586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estrogens. Contraceptive therapy].
    Sojo-Aranda I; Cortés-Gallegos V
    Ginecol Obstet Mex; 1995 Jan; 63():46-9. PubMed ID: 7896159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
    Lippman JS; Shangold GA
    Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxicological requirement of oral contraceptives.
    Fairweather FA
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:47-9. PubMed ID: 5288231
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of oral contraceptives on vitamin B6 nutriture of young women.
    Vir SC; Love AH
    Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA approves new oral contraceptive.
    FDA Consum; 2003; 37(6):5. PubMed ID: 14983808
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of short term use of oral contraceptives on fibrinolytic activity of the blood.
    Dabholkar NA; Rane VA
    Curr Med Pract; 1973; 17(5):201-3. PubMed ID: 12333541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary metabolites of radioactive quinestrol in rabbits.
    Layne DS; Williams KI
    Int J Fertil; 1967; 12(2):158-63. PubMed ID: 6033892
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of the secondary effects associated with taking a triphasic anti-ovulatory contraceptive].
    Vekemans M
    Rev Med Brux; 1984 Jan; 5(1):13-9. PubMed ID: 6701404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy associated with a combined oral contraceptive and itraconazole.
    Hingston GR
    N Z Med J; 1993 Dec; 106(969):528. PubMed ID: 8043097
    [No Abstract]   [Full Text] [Related]  

  • 38. [Myasthenia and oral contraceptives (a case report)].
    Kiehl U
    Z Arztl Fortbild (Jena); 1984; 78(4):153-4. PubMed ID: 6711038
    [No Abstract]   [Full Text] [Related]  

  • 39. In-vivo and in-vitro metabolism of ethynyloestradiol.
    Reed MJ; Fotherby K; Steele SJ; Addison J
    J Endocrinol; 1972 Jun; 53(3):28-9. PubMed ID: 5039215
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective on-line trace enrichment for the determination of ethynyl steroids in urine by liquid chromatography with precolumn technology.
    Nielen MW; van Soest RE; van Ingen HE; Farjam A; Frei RW; Brinkman UA
    J Chromatogr; 1987 Jun; 417(1):159-67. PubMed ID: 3624393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.